Population Health Sciences

You are here

Home > Publications > Publications

Publications

Found 169 results
Author Title [ Type(Desc)] Year
Filters: First Letter Of Last Name is H  [Clear All Filters]
Journal Article
Shonkoff SBC, Hays J, Finkel ML.  2014.  Environmental public health dimensions of shale and tight gas development.. Environ Health Perspect. 122(8):787-95.
Berry K, Pesko MF, Hesdorffer DC, Shellhaas RA, Seirup JK, Grinspan ZM.  2017.  An evaluation of national birth certificate data for neonatal seizure epidemiology.. Epilepsia. 58(3):446-455.
Stiles BM, Mao J, Harrison S, Lee B, Port JL, Sedrakyan A, Altorki NK.  2019.  Extent of lymphadenectomy is associated with oncological efficacy of sublobar resection for lung cancer ≤2 cm.. J Thorac Cardiovasc Surg. 157(6):2454-2465.e1.
Creber RMMasterso, Baldwin MR, Brown PJ, Rao MK, Goyal P, Hummel S, Dodson JA, Helmke S, Maurer MS.  2019.  Facilitated Peer Mentorship to Support Aging Research: A RE-AIM Evaluation of the CoMPAdRE Program.. J Am Geriatr Soc. 67(4):804-810.
Creber RMMasterso, Baldwin MR, Brown PJ, Rao MK, Goyal P, Hummel S, Dodson JA, Helmke S, Maurer MS.  2019.  Facilitated Peer Mentorship to Support Aging Research: A RE-AIM Evaluation of the CoMPAdRE Program.. J Am Geriatr Soc. 67(4):804-810.
Russell D, Baik D, Jordan L, Dooley F, Hummel SL, Prigerson HG, Bowles KH, Creber RMasterson.  2019.  Factors Associated With Live Discharge of Heart Failure Patients From Hospice: A Multimethod Study.. JACC Heart Fail. 7(7):550-557.
Armer JM, Ballman KV, McCall L, Ostby PL, Zagar E, Kuerer HM, Hunt KK, Boughey JC.  2019.  Factors Associated With Lymphedema in Women With Node-Positive Breast Cancer Treated With Neoadjuvant Chemotherapy and Axillary Dissection.. JAMA Surg.
Hafeez B, Paolicchi J, Pon S, Howell JD, Grinspan ZM.  2016.  Feasibility of Automatic Extraction of Electronic Health Data to Evaluate a Status Epilepticus Clinical Protocol.. J Child Neurol. 31(6):709-16.
Hafeez B, Paolicchi J, Pon S, Howell JD, Grinspan ZM.  2016.  Feasibility of Automatic Extraction of Electronic Health Data to Evaluate a Status Epilepticus Clinical Protocol.. J Child Neurol. 31(6):709-16.
Ali SB, Romero J, Morrison K, Hafeez B, Ancker JS.  2018.  Focus Section Health IT Usability: Applying a Task-Technology Fit Model to Adapt an Electronic Patient Portal for Patient Work.. Appl Clin Inform. 9(1):174-184.
Weiss P, Myers AL, McGann KA, Mason KE, Kesselheim JC, Fleming G, Barron C, Klasner A, Heyman MB, Weiss DL et al..  2019.  Funding Sources and Perceived Financial Insecurity in Pediatric Subspecialty Fellowship Programs.. Acad Pediatr. 19(7):815-821.
Liu J, van der Smissen WJCPrager, J Collée M, Bolla MK, Wang Q, Michailidou K, Dennis J, Ahearn TU, Aittomäki K, Ambrosone CB et al..  2020.  Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.. Sci Rep. 10(1):9688.
Liu J, van der Smissen WJCPrager, J Collée M, Bolla MK, Wang Q, Michailidou K, Dennis J, Ahearn TU, Aittomäki K, Ambrosone CB et al..  2020.  Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.. Sci Rep. 10(1):9688.
Liu J, van der Smissen WJCPrager, J Collée M, Bolla MK, Wang Q, Michailidou K, Dennis J, Ahearn TU, Aittomäki K, Ambrosone CB et al..  2020.  Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.. Sci Rep. 10(1):9688.
Liu J, van der Smissen WJCPrager, J Collée M, Bolla MK, Wang Q, Michailidou K, Dennis J, Ahearn TU, Aittomäki K, Ambrosone CB et al..  2020.  Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.. Sci Rep. 10(1):9688.
Liu J, van der Smissen WJCPrager, J Collée M, Bolla MK, Wang Q, Michailidou K, Dennis J, Ahearn TU, Aittomäki K, Ambrosone CB et al..  2020.  Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.. Sci Rep. 10(1):9688.
Liu J, van der Smissen WJCPrager, J Collée M, Bolla MK, Wang Q, Michailidou K, Dennis J, Ahearn TU, Aittomäki K, Ambrosone CB et al..  2020.  Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.. Sci Rep. 10(1):9688.
Liu J, van der Smissen WJCPrager, J Collée M, Bolla MK, Wang Q, Michailidou K, Dennis J, Ahearn TU, Aittomäki K, Ambrosone CB et al..  2020.  Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.. Sci Rep. 10(1):9688.
Liu J, van der Smissen WJCPrager, J Collée M, Bolla MK, Wang Q, Michailidou K, Dennis J, Ahearn TU, Aittomäki K, Ambrosone CB et al..  2020.  Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.. Sci Rep. 10(1):9688.
Liu J, van der Smissen WJCPrager, J Collée M, Bolla MK, Wang Q, Michailidou K, Dennis J, Ahearn TU, Aittomäki K, Ambrosone CB et al..  2020.  Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.. Sci Rep. 10(1):9688.
Liu J, van der Smissen WJCPrager, J Collée M, Bolla MK, Wang Q, Michailidou K, Dennis J, Ahearn TU, Aittomäki K, Ambrosone CB et al..  2020.  Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.. Sci Rep. 10(1):9688.
Liu J, van der Smissen WJCPrager, J Collée M, Bolla MK, Wang Q, Michailidou K, Dennis J, Ahearn TU, Aittomäki K, Ambrosone CB et al..  2020.  Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.. Sci Rep. 10(1):9688.
Liu J, van der Smissen WJCPrager, J Collée M, Bolla MK, Wang Q, Michailidou K, Dennis J, Ahearn TU, Aittomäki K, Ambrosone CB et al..  2020.  Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.. Sci Rep. 10(1):9688.
Liu J, van der Smissen WJCPrager, J Collée M, Bolla MK, Wang Q, Michailidou K, Dennis J, Ahearn TU, Aittomäki K, Ambrosone CB et al..  2020.  Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.. Sci Rep. 10(1):9688.
Liu J, van der Smissen WJCPrager, J Collée M, Bolla MK, Wang Q, Michailidou K, Dennis J, Ahearn TU, Aittomäki K, Ambrosone CB et al..  2020.  Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk.. Sci Rep. 10(1):9688.